1,384 followers
A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer by Wanjun Yu https://t.co/tTrn2R9TBu
A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer by Wanjun Yu https://t.co/tTrn2R9TBu
New article: A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer https://t.co/SvIvBgcIIx #lungcancer #oncology https://t.co/G93zGpGK1T